Salvati; Mark E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Salvati; Mark E..The latest application filed is for "anti-il1rap antibodies, bispecific antigen binding molecules that bind il1rap and cd3, and uses thereof".

Company Profile

0.33.38

Salvati; Mark E. - Spring House PA
Salvati; Mark E. - Pennington NJ
Salvati; Mark E. - Lawrenceville NJ
Salvati; Mark E. - Lawrencevile NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-il1rap Antibodies, Bispecific Antigen Binding Molecules That Bind Il1rap And Cd3, And Uses Thereof App 20190270826 - Heidrich; Bradley J. ; et al.	2019-09-05
Anti-il1rap Antibodies, Bispecific Antigen Binding Molecules That Bind Il1rap And Cd3, And Uses Thereof App 20170121420 - Heidrich; Bradley J. ; et al.	2017-05-04
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases Grant 9,102,599 - Salvati , et al. August 11, 2	2015-08-11
Heterocyclic CETP inhibitors Grant 8,642,576 - Salvati , et al. February 4, 2	2014-02-04
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine Derivatives As Cetp Inhibitors For The Treatment Of Atherosclerosis And Cardiovascular Diseases App 20130184279 - Salvati; Mark E. ; et al.	2013-07-18
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases Grant 8,404,896 - Salvati , et al. March 26, 2	2013-03-26
Heterocyclic Cetp Inhibitors App 20120322761 - Salvati; Mark E. ; et al.	2012-12-20
Heterocyclic CETP inhibitors Grant 8,304,403 - Salvati , et al. November 6, 2	2012-11-06
Heterocyclic CETP inhibitors Grant 7,888,376 - Salvati , et al. February 15, 2	2011-02-15
Heterocyclic Cetp Inhibitors App 20100267669 - Salvati; Mark E. ; et al.	2010-10-21
Heterocyclic CETP inhibitors Grant 7,790,770 - Salvati , et al. September 7, 2	2010-09-07
Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function Grant 7,776,859 - Balog , et al. August 17, 2	2010-08-17
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine Derivatives As Cetp Inhibitors For The Treatment Of Atherosclerosis And Cardiovascular Diseases App 20100041717 - Salvati; Mark E. ; et al.	2010-02-18
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,655,689 - Salvati , et al. February 2, 2	2010-02-02
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,655,688 - Salvati , et al. February 2, 2	2010-02-02
Tricycloundecane compounds useful as modulators of nuclear hormone receptor function Grant 7,550,458 - Balog , et al. June 23, 2	2009-06-23
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,517,904 - Salvati , et al. April 14, 2	2009-04-14
Fused heterocyclic imido and amido compounds Grant 7,470,797 - Salvati , et al. December 30, 2	2008-12-30
Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function Grant 7,468,439 - Shan , et al. December 23, 2	2008-12-23
Fused cyclic modulators of nuclear hormone receptor function Grant 7,432,267 - Salvati , et al. October 7, 2	2008-10-07
Fused Heterocyclic Succinimide Compounds And Analogs Thereof, Modulators Of Nuclear Hormone Receptor Function App 20080214643 - Salvati; Mark E. ; et al.	2008-09-04
Alkylene Bridged Sultam Compounds Useful As Modulators Of Nuclear Hormone Receptor Function App 20080090883 - Shan; Weifang ; et al.	2008-04-17
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,342,034 - Salvati , et al. March 11, 2	2008-03-11
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,291,637 - Salvati , et al. November 6, 2	2007-11-06
Heterocyclic Cetp Inhibitors App 20070161685 - Salvati; Mark E. ; et al.	2007-07-12
Heterocyclic Cetp Inhibitors App 20070135631 - Salvati; Mark E. ; et al.	2007-06-14
Crystallographic structure of the androgen receptor ligand binding domain Grant 7,225,083 - Weinmann , et al. May 29, 2	2007-05-29
Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function App 20070088039 - Balog; James Aaron ; et al.	2007-04-19
Tricycloundecane compounds useful as modulators of nuclear hormone receptor function App 20070088029 - Balog; James Aaron ; et al.	2007-04-19
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,141,578 - Salvati , et al. November 28, 2	2006-11-28
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060264459 - Salvati; Mark E. ; et al.	2006-11-23
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060223832 - Salvati; Mark E. ; et al.	2006-10-05
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,087,636 - Salvati , et al. August 8, 2	2006-08-08
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060111424 - Salvati; Mark E. ; et al.	2006-05-25
Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders Grant 7,030,112 - Salvati , et al. April 18, 2	2006-04-18
Fused cyclic modulators of nuclear hormone receptor function Grant 7,001,911 - Salvati , et al. February 21, 2	2006-02-21
Bicyclic modulators of androgen receptor function Grant 6,992,102 - Hamann , et al. January 31, 2	2006-01-31
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060020002 - Salvati; Mark E. ; et al.	2006-01-26
Fused cyclic modulators of nuclear hormone receptor function App 20050282813 - Salvati, Mark E. ; et al.	2005-12-22
Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050272799 - Salvati, Mark E. ; et al.	2005-12-08
Selective androgen receptor modulators and methods for their identification, design and use App 20050256048 - Salvati, Mark E. ; et al.	2005-11-17
Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator Grant 6,960,474 - Salvati , et al. November 1, 2	2005-11-01
Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof Grant 6,953,679 - Salvati , et al. October 11, 2	2005-10-11
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050192253 - Salvati, Mark E. ; et al.	2005-09-01
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050187273 - Salvati, Mark E. ; et al.	2005-08-25
Piperazine derivatives and their use as modulators of nuclear hormone receptor function App 20050124625 - Salvati, Mark E. ; et al.	2005-06-09
Method For The Preparation Of Fused Heterocyclic Succinimide Compounds And Analogs Thereof App 20050119228 - Salvati, Mark E. ; et al.	2005-06-02
Process for preparing azacycloalkanoylaminothiazoles (LD 137e) Grant 6,897,321 - Chen , et al. May 24, 2	2005-05-24
Crystallographic structure of the androgen receptor ligand binding domain App 20040243316 - Weinmann, Roberto ; et al.	2004-12-02
Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders App 20040209886 - Salvati, Mark E. ; et al.	2004-10-21
Crystallographic structure of the androgen receptor ligand binding domain Grant 6,795,776 - Weinmann , et al. September 21, 2	2004-09-21
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20040176324 - Salvati, Mark E. ; et al.	2004-09-09
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20040087548 - Salvati, Mark E. ; et al.	2004-05-06
Fused cyclic modulators of nuclear hormone receptor function App 20040077606 - Salvati, Mark E. ; et al.	2004-04-22
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20040077605 - Salvati, Mark E. ; et al.	2004-04-22
Process for preparing azacycloalkanoylaminothiazoles (LD 137e) App 20040063767 - Chen, Bang-Chi ; et al.	2004-04-01
Bicyclic modulators of androgen receptor function Grant 6,670,386 - Sun , et al. December 30, 2	2003-12-30
Process for preparing azacycloalkanoylaminothiazoles Grant 6,639,074 - Chen , et al. October 28, 2	2003-10-28
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function App 20030181728 - Salvati, Mark E. ; et al.	2003-09-25
3-Aminopyrazole inhibitors of cyclin dependent kinases Grant 6,610,724 - Salvati , et al. August 26, 2	2003-08-26
Fused cyclic modulators of nuclear hormone receptor function App 20030114420 - Salvati, Mark E. ; et al.	2003-06-19
Bicyclic modulators of androgen receptor function App 20030055094 - Sun, Chongqing ; et al.	2003-03-20
3-aminopyrazole inhibitors of cyclin dependent kinases App 20030018058 - Salvati, Mark E. ; et al.	2003-01-23
Selective androgen receptor modulators and methods for their identification, design and use App 20020173445 - Salvati, Mark E. ; et al.	2002-11-21
Process for preparing azacycloalkanoylaminothiazoles App 20020099217 - Chen, Bang-Chi ; et al.	2002-07-25
3-Aminopyrazole inhibitors of cyclin dependent kinases App 20010047019 - Salvati, Mark E. ; et al.	2001-11-29
Substituted 3-cyanoquinolines Grant 6,288,082 - Wissner , et al. September 11, 2	2001-09-11
Process for preparing azacycloalkanoylaminothiazoles App 20010006976 - Chen, Bang-Chi ; et al.	2001-07-05
Substituted dibenzothiophenes having antiangiogenic activity Grant 6,022,307 - Salvati , et al. February 8, 2	2000-02-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.